Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetes
NCT01322789Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2008
- Primary completion
- Nov 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in type 1 diabetes mellitus (T1D), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01322789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01322789.